RB
Rosebud Biosciences develops targeted therapies for rare genetic diseases in children by utilizing organoids that replicate the child's specific genetic mutations. This approach enables the screening of potential drug treatments in a human-like model, addressing the significant lack of approved therapies for 95% of these conditions.
Updated 20 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Rosebud Biosciences develops targeted therapies for rare genetic diseases in children by utilizing organoids that replicate the child's specific genetic mutations. This approach enables the screening of potential drug treatments in a human-like model, addressing the significant lack of approved therapies for 95% of these conditions.